BAA-effectiveness research with real world data to support FDA's regulatory decision making
Ended Definitive Contract Awarded Last action
- Contract number
- HHSF223201710186C
- Awardee
-
Brigham & Womens Hospital Inc. UEI QN6MS4VN7BD1 Part of Partners Healthcare System Incorporated
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,082,291
Award facts
- Opportunity
-
- FDABAA1700123 Solicitation number
- Contract value 100% obligated
- $2,082,291.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02115, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $692,985 | |
| Original award | $1,389,306 |
About this award
The Department of Health and Human Services Food and Drug Administration awarded a $2,082,291.00 firm fixed price definitive contract to Brigham & Women's Hospital Inc., a non-profit hospital and research institution in Boston, Massachusetts. The contract is for "Effectiveness Research with Real World Data to Support FDA's Regulatory Decision Making." It does not have a set-aside designation.
Under the contract, Brigham & Women's Hospital is working closely with the FDA's Division of Pharmacoepidemiology to implement healthcare database studies to replicate 30 randomized controlled trials. Aetion Inc., a for-profit company, is a major subcontractor providing data analysis software, technical support, and training. This contract appears to support the FDA's efforts to leverage real-world data and evidence to inform its regulatory decision making.
Quick answers
Who was awarded contract HHSF223201710186C?
HHSF223201710186C was awarded to Brigham & Womens Hospital Inc. by Food and Drug Administration (Department of Health and Human Services) on September 21, 2017.
How much is contract HHSF223201710186C worth?
The government has obligated $2,082,291 on HHSF223201710186C.
Was contract HHSF223201710186C competed?
The extent of competition for HHSF223201710186C was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award